Korea Signs Deals With Roche, GSK For More Tamiflu, Relenza

SEOUL - Alarmed by the rising number of people infected with the H1N1 virus in neighboring Japan, and in Korea, the South Korean government has signed contracts recently to secure more of Roche's Tamiflu (oseltamivir) and GlaxoSmithKline's Relenza (zanamivir)